Conditional Approval Act

United States116th CongressHR-5497House of Representatives
Updated: Dec 20, 2019

Summary

Conditional Approval Act This bill authorizes the Food and Drug Administration to conditionally approve certain new drugs intended for diseases that are seriously debilitating, life threatening, or chronic, and for which meaningful treatments do not exist. The bill also limits liability related to these conditionally approved drugs.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-3133: Conditional Approval Act

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  1. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.